Citation Impact
Citing Papers
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells
2013
Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo
2005
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Resveratrol modulates the phosphoinositide 3‐kinase pathway through an estrogen receptor α‐dependent mechanism: Relevance in cell proliferation
2003
Nutraceuticals: Facts and fiction
2007 Standout
Effects of Flavonoids and other Polyphenols on Inflammation
2011 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Cancer to bone: a fatal attraction
2011 Standout
The Thrombospondins
2011 Standout
Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis
2007
A Review of the Effects and Mechanisms of Polyphenolics in Cancer
2006
PrognoScan: a new database for meta-analysis of the prognostic value of genes
2009
Halloysite Clay Nanotubes for Resveratrol Delivery to Cancer Cells
2012
Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex
2009
Mouse Bioassay to Assess Oestrogenic and Anti‐oestrogenic Compounds: Hydroxytamoxifen, Diethylstilbestrol and Genistein
2004
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
Resveratrol‐induced apoptosis in MCF‐7 human breast cancer cells involves a caspase‐independent mechanism with downregulation of Bcl‐2 and NF‐κB
2005
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Transient potential receptor channel 4 controls thrombospondin‐1 secretion and angiogenesis in renal cell carcinoma
2007
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Modern Synthetic Methods for Fluorine‐Substituted Target Molecules
2004 Standout
Targeting prostate cancer angiogenesis through metastasis‐associated protein 1 (MTA1)
2010
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
2014 Standout
Herbal bioactivation: The good, the bad and the ugly
2003
Wine and resveratrol: mechanisms of cancer prevention?
2003
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
Resveratrol as an anticancer nutrient: molecular basis, open questions and promises
2005
GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: A comprehensive meta-analysis
2010 Standout
Biological effects of essential oils – A review
2007 Standout
LPS Induces Hypoxia-Inducible Factor 1 Activation in Macrophage-Differentiated Cells in a Reactive Oxygen Species–Dependent Manner
2008 StandoutNobel
Heme Oxygenase-1 in Tumors: Is It a False Friend?
2007
Plant Phenolics: Extraction, Analysis and Their Antioxidant and Anticancer Properties
2010 Standout
Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray
2003
Resveratrol: Preventing properties against vascular alterations and ageing
2005
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Estrogen Receptors as Therapeutic Targets in Breast Cancer
2008
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
2004 Standout
Phenolics and polyphenolics in foods, beverages and spices: Antioxidant activity and health effects – A review
2015 Standout
Selective Estrogen Receptor Modulators
2004
Properties of Resveratrol:In VitroandIn VivoStudies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans
2015 Standout
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
An Extensive New Literature Concerning Low-Dose Effects of Bisphenol A Shows the Need for a New Risk Assessment
2005 Standout
Targeting MCT-1 oncogene inhibits Shc pathway and xenograft tumorigenicity
2012
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
Resveratrol stimulates nitric oxide production by increasing estrogen receptor αa‐Src‐caveolin‐1 interaction and phosphorylation in human umbilical vein endothelial cells
2008
Mediterranean diet pyramid today. Science and cultural updates
2011 Standout
Chemical studies of anthocyanins: A review
2008 Standout
Halloysite Clay Nanotubes for Loading and Sustained Release of Functional Compounds
2015 Standout
Significance of wine and resveratrol in cardiovascular disease: French paradox revisited.
2006
Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
2003
Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications
2005
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
2006 StandoutScience
Works of Laura Simons being referenced
Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER α
2003
Molecular classification of estrogens.
2001
Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor.
2002
MCT-1 Oncogene Contributes to Increased In vivo Tumorigenicity of MCF7 Cells by Promotion of Angiogenesis and Inhibition of Apoptosis
2005